Latest News
New research by NIH-funded scientists has revealed evidence that viral species, particularly herpesviruses, could contribute toward the complex biology underlying Alzheimer’s disease.
In an international collaboration, researchers have determined that psychiatric disorders may have important molecular similarities that are not reflected in current diagnostic categories.
Dopamine agonists and prodrugs taken to treat Parkinson’s disease may cause impulse control disorders in over half the patients they are prescribed to.
Journal Articles
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
Investigational gene therapy licensed for Parkinson’s disease: industry news round-up
International Nurses Day: a day in the life of Lynn Hundley
International Nurses Day: a day in the life of Ismalia de Sousa
CNS/PNS/SNS
Spinal cord injuries could be repaired by stem cell-based therapy
Can myelin stimulate neuron growth in spinal cord injuries?
Reprogrammed neuronal stem cells survive long-term in spinal cord injury model
Cognitive/neurodegenerative disorders
Do viruses play a role in Alzheimer’s disease?
Parkinson’s drugs may cause impulse control disorders
Alzheimer’s Society Annual Conference 2018: Making progress in dementia research
Demyelinating disease
World Multiple Sclerosis Day – a note from the Editor
NCTalks with Jens Kuhle: monitoring multiple sclerosis using blood neurofilament light protein
Multiple sclerosis: new UK guidelines on disease-modifying therapies
Development and pediatrics
Genes associated with infantile forms of schizophrenia identified
Investigational gene therapy licensed for Parkinson’s disease: industry news round-up
Genes, environment and schizophrenia: is the placenta the missing link?
Epilepsy and seizure
Epilepsy and cannabinoids: current consensus, controversies and future outlook
Reports of brain damage call a halt to Bellicum trials: industry news round-up
Could novel epileptic encephalopathy genes promote advances in treatment strategy?
Genetics
Could psychiatric disorders share an underlying genetic basis?
Genes, environment and schizophrenia: is the placenta the missing link?
UK Biobank: new genetic risk factors for Alzheimer’s disease identified
Headache
Aimovig® receives positive CHMP opinion for the prevention of migraine
Aimovig® gains US FDA approval for the preventive treatment of migraine
Immune disorders and inflammation
Could hyaluronic acid contribute to chronic white matter injury?
NCTalks at SfN17: Doris Doudet on Parkinson's, inflammation and the gut
Infection
Do viruses play a role in Alzheimer’s disease?
Injury/trauma
Spinal cord injuries could be repaired by stem cell-based therapy
Can myelin stimulate neuron growth in spinal cord injuries?
Reprogrammed neuronal stem cells survive long-term in spinal cord injury model
Movement disorders
Parkinson’s drugs may cause impulse control disorders
Is there a link between diabetes and Parkinson’s disease?
Multiple sclerosis: new UK guidelines on disease-modifying therapies
Neuro-ophthalmology
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Glaucoma research gives a glimpse of a novel neuroprotection mechanism
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Could psychiatric disorders share an underlying genetic basis?
Genes associated with infantile forms of schizophrenia identified
Oncology/tumor
Brain metastases could be tackled using new therapy with silibinin
World Brain Tumor Day: cancer prevention advice and common perceptions
Pain
Aimovig® gains US FDA approval for the preventive treatment of migraine
Sleep
#NCIntroduces... Sleep science
Better sleep works like a dream at reducing fear learning
Sleep research realizes the dream of understanding brain plasticity mechanisms
